Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

The American Journal of Medicine

Volumn 85, Issue 5, 1988, Pages 602-608

  Kalunian, Kenneth C ^a   Middlekauff, Holly R ^a   Sayre, James ^a   Ando, Dale G ^a   Mangotich, Maureen ^a   Hahn, Bevra H ^a   Peter, James B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Specialty Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN;

HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

ADULT; AGED; ANTIBODIES; CARDIOLIPINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL DEATH; HUMAN; IMMUNOGLOBULIN ISOTYPES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; PREGNANCY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOSIS;

EID: 0024205263     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(88)80229-8     Document Type: Article

References (29)

1. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
2. Anti-phospholipid antibodies
3. The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of 60 consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level
4. Thrombocytopenia in systemic lupus erythematosus and related autoimmune disorders
5. Anticardiolipin antibodies in autoimmune thrombocytopenia purpura
6. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus
7. Fetal loss in systemic lupus: association with anticardiolipin antibodies
8. A prospective study of anticardiolipin antibodies in hospitalized systemic lupus erythematosus patients (abstr)
9. Anticardiolipin antibodies in patients with rheumatic diseases
10. Anticardiolipin antibodies in patients with systemic lupus erythematosus
11. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results
12. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986
13. The 1982 revised criteria for the classification . of systemic lupus erythematosus
14. Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay: a clinical study of NZB/W F1 mice
15. Affinity purified anti-cardiolipin and anti-DNA antibodies
16. Thrombosis in systemic lupus erythematosus: striking associations with the presence of circulating lupus anticoagulant
17. The lupus anticoagulant a disease marker in antinuclear antibody negative lupus that is cross reactive with autoantibodies to doublestranded DNA
18. The association between anti-DNA antibodies and the lupus anticoagulant (abstr)
19. Antiphospholipid antibody isotypes in systemic lupus erythematosus (abstr)
20. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant
21. Anticardiolipin antibody quantitation (letter)
22. Lupus anticoagulant and thrombosis—possible role of inhibition of prostacyclin formation
23. Arterial thrombosis, intrauterine death and the lupus anticoagulant
24. Cerebral hemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for “spontaneous” cerebral venous thrombosis
25. Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis
26. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage
27. Obstetric complications associated with the lupus anticoagulant
28. Anticardiolipin antibodies: isotype distribution and phospholipid specificity